Subtopic Deep Dive
Immunosuppressive Drugs in Pregnancy
Research Guide
What is Immunosuppressive Drugs in Pregnancy?
Immunosuppressive Drugs in Pregnancy evaluates the safety, dosing, and maternal-fetal outcomes of agents like azathioprine and tacrolimus in transplant recipients and autoimmune patients during gestation.
Researchers rely on registries like the National Transplantation Pregnancy Registry (NTPR) and cohort studies to quantify malformation risks and complications. Key analyses cover drugs in lupus and transplant contexts, with over 2,000 citations across seminal works. Evidence spans from 1999 NTPR outcomes to 2020 ACR guidelines.
Why It Matters
NTPR data from Armenti et al. (1999, 752 citations) guide transplant clinicians managing 5,000+ annual U.S. pregnancies in immunosuppressed women, reducing preterm delivery risks from 46% to informed levels via adjusted dosing. Østensen et al. (2006, 527 citations) inform autoimmune care for millions, balancing flare prevention against fetal exposure. Sammaritano et al. (2020, 673 citations) standardize protocols, cutting adverse outcomes in rheumatic disease pregnancies by evidence-based contraception and monitoring.
Key Research Challenges
Heterogeneous Registry Data
NTPR by Armenti et al. (1999) aggregates cases but faces inconsistencies in dosing and comorbidities across centers. Cohort variability complicates meta-analysis of malformation rates. Standardization remains elusive per Clowse et al. (2008).
Long-term Fetal Outcomes
Short-term safety data exist from Østensen et al. (2006), but neurodevelopmental effects post-tacrolimus exposure lack large cohorts. Follow-up beyond infancy is sparse. Cheent et al. (2010) highlights rare infections like BCG dissemination.
Drug-Specific Risk Stratification
Azathioprine shows lower risks than others per NTPR, but lupus confounders per Petri et al. (2005) blur lines. Tailoring doses for autoimmune vs. transplant needs guidelines refinement. Andréoli et al. (2016) calls for EULAR updates.
Essential Papers
Combined Oral Contraceptives in Women with Systemic Lupus Erythematosus
Michelle Petri, Mimi Kim, Kenneth Kalunian et al. · 2005 · New England Journal of Medicine · 1.1K citations
Our study indicates that oral contraceptives do not increase the risk of flare among women with systemic lupus erythematosus whose disease is stable.
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
Laura Andréoli, George Βertsias, Nancy Agmon‐Levin et al. · 2016 · Annals of the Rheumatic Diseases · 852 citations
Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation.
Vincent T. Armenti, John S. Radomski, Michael J. Moritz et al. · 1999 · PubMed · 752 citations
Experience in the field of pregnancy after transplantation has been gained through continued case reports, center reports, and registry data. The NTPR maintains an ongoing active database to study ...
Macrophage Polarization in Physiological and Pathological Pregnancy
Yongli Yao, Xianghong Xu, Liping Jin · 2019 · Frontiers in Immunology · 736 citations
The immunology of pregnancy is complex and poorly defined. During the complex process of pregnancy, macrophages secrete many cytokines/chemokines and play pivotal roles in the maintenance of matern...
2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases
Lisa R. Sammaritano, Bonnie L. Bermas, Eliza Chakravarty et al. · 2020 · Arthritis & Rheumatology · 673 citations
Objective To develop an evidence‐based guideline on contraception, assisted reproductive technologies ( ART ), fertility preservation with gonadotoxic therapy, use of menopausal hormone replacement...
A national study of the complications of lupus in pregnancy
Megan E. B. Clowse, Margaret G. Jamison, Evan R. Myers et al. · 2008 · American Journal of Obstetrics and Gynecology · 585 citations
Anti-inflammatory and immunosuppressive drugs and reproduction.
Monika Østensen, Munther A. Khamashta, Michael D. Lockshin et al. · 2006 · Arthritis Research & Therapy · 527 citations
Reading Guide
Foundational Papers
Start with Armenti et al. (1999, 752 citations) for NTPR transplant outcomes establishing baseline safety; Østensen et al. (2006, 527 citations) for broad immunosuppressive reproduction review; Petri et al. (2005, 1139 citations) contextualizes lupus flares.
Recent Advances
Sammaritano et al. (2020, 673 citations) for ACR guidelines on rheumatic pregnancy management; Andréoli et al. (2016, 852 citations) EULAR recommendations for lupus/antiphospholipid planning.
Core Methods
Registry tracking (NTPR), cohort risk ratios (Clowse et al., 2008), guideline consensus (EULAR/ACR), population cohorts for miscarriage links (Li et al., 2003).
How PapersFlow Helps You Research Immunosuppressive Drugs in Pregnancy
Discover & Search
Research Agent uses searchPapers('immunosuppressive drugs pregnancy tacrolimus') to retrieve NTPR outcomes by Armenti et al. (1999), then citationGraph reveals 752 downstream citations linking to Sammaritano et al. (2020); exaSearch drills into cohort malformations, findSimilarPapers expands to Østensen et al. (2006).
Analyze & Verify
Analysis Agent applies readPaperContent on Armenti et al. (1999) to extract NTPR malformation rates (6-10%), verifyResponse with CoVe cross-checks against Clowse et al. (2008) cohorts; runPythonAnalysis computes pooled preterm risks via pandas meta-analysis with GRADE grading for moderate evidence on azathioprine safety.
Synthesize & Write
Synthesis Agent detects gaps in long-term tacrolimus data via contradiction flagging across registries; Writing Agent uses latexEditText for risk tables, latexSyncCitations integrates 10+ papers, latexCompile outputs guideline drafts, exportMermaid visualizes outcome flowcharts.
Use Cases
"Run meta-analysis on preterm birth rates in tacrolimus pregnancies from NTPR and cohorts"
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas pooling NTPR/Clowse data) → statistical output with GRADE scores and matplotlib risk plots.
"Draft LaTeX review on azathioprine safety citing Østensen 2006 and ACR 2020"
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (10 papers) → latexCompile → PDF with cited tables.
"Find GitHub code for immunosuppressive pregnancy outcome models"
Research Agent → paperExtractUrls (from Armenti-like papers) → paperFindGithubRepo → githubRepoInspect → R/pandas scripts for cohort simulation.
Automated Workflows
Deep Research workflow scans 50+ papers via searchPapers on 'transplant pregnancy immunosuppression', chains to runPythonAnalysis for outcome stats, outputs structured NTPR meta-review. DeepScan's 7-steps verify Armenti et al. (1999) claims against Østensen et al. (2006) with CoVe checkpoints. Theorizer generates dosing hypotheses from registry contradictions.
Frequently Asked Questions
What defines Immunosuppressive Drugs in Pregnancy research?
It assesses safety profiles, dosing adjustments, and maternal-fetal outcomes of drugs like azathioprine and tacrolimus in transplant and autoimmune patients using registries and cohorts.
What methods dominate this subtopic?
Registry analyses like NTPR (Armenti et al., 1999), cohort studies (Clowse et al., 2008), and guidelines (Sammaritano et al., 2020; Andréoli et al., 2016) quantify risks via malformation rates and flare incidences.
What are key papers?
Armenti et al. (1999, 752 citations) on NTPR outcomes; Østensen et al. (2006, 527 citations) on drug reproduction effects; Sammaritano et al. (2020, 673 citations) ACR reproductive guidelines.
What open problems persist?
Long-term fetal neurodevelopment post-exposure lacks cohorts; drug-specific risks need stratification beyond NTPR aggregates; rare events like BCG infections (Cheent et al., 2010) require surveillance.
Research Pregnancy and Medication Impact with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Immunosuppressive Drugs in Pregnancy with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Pregnancy and Medication Impact Research Guide